NCT07027982View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

August 14, 2025

Study Completion Date

August 14, 2025

Conditions
Healthy Adults
Interventions
DRUG

Diluted Intravenous DA-5217

once a day

DRUG

Undiluted Intravenous DA-5217

once a day

Trial Locations (1)

13605

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY